GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Qingdao Haier Biomedical Co Ltd (SHSE:688139) » Definitions » Market Cap

Qingdao Haier Biomedical Co (SHSE:688139) Market Cap : ¥11,214 Mil (As of Dec. 13, 2024)


View and export this data going back to 2019. Start your Free Trial

What is Qingdao Haier Biomedical Co Market Cap?

Market cap is the total market value to buy the whole company. It is equal to the share price times the number of Shares Outstanding (EOP). Qingdao Haier Biomedical Co's share price for the quarter that ended in Sep. 2024 was ¥34.9. Qingdao Haier Biomedical Co's Shares Outstanding (EOP) for the quarter that ended in Sep. 2024 was 318 Mil. Therefore, Qingdao Haier Biomedical Co's market cap for the quarter that ended in Sep. 2024 was ¥11,097 Mil.

Qingdao Haier Biomedical Co's quarterly market cap increased from Mar. 2024 (¥8,969 Mil) to Jun. 2024 (¥11,828 Mil) but then declined from Jun. 2024 (¥11,828 Mil) to Sep. 2024 (¥11,097 Mil).

Qingdao Haier Biomedical Co's annual market cap declined from Dec. 2021 (¥28,796 Mil) to Dec. 2022 (¥20,126 Mil) and declined from Dec. 2022 (¥20,126 Mil) to Dec. 2023 (¥12,883 Mil).

Enterprise Value is the theoretical takeover price. It is more comprehensive than market capitalization (market cap), which only includes common equity. Enterprise Value is calculated as the market cap plus debt and minority interest and preferred shares, minus total cash and cash equivalents. Qingdao Haier Biomedical Co's Enterprise Value for Today is ¥9,683 Mil.


Qingdao Haier Biomedical Co Market Cap Historical Data

The historical data trend for Qingdao Haier Biomedical Co's Market Cap can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Qingdao Haier Biomedical Co Market Cap Chart

Qingdao Haier Biomedical Co Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Market Cap
Get a 7-Day Free Trial 9,157.04 20,701.63 28,796.48 20,126.42 12,883.46

Qingdao Haier Biomedical Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
Market Cap Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 12,174.42 12,883.46 8,969.45 11,827.85 11,096.56

Competitive Comparison of Qingdao Haier Biomedical Co's Market Cap

For the Medical Devices subindustry, Qingdao Haier Biomedical Co's Market Cap, along with its competitors' market caps and Market Cap data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Qingdao Haier Biomedical Co's Market Cap Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Qingdao Haier Biomedical Co's Market Cap distribution charts can be found below:

* The bar in red indicates where Qingdao Haier Biomedical Co's Market Cap falls into.



Qingdao Haier Biomedical Co Market Cap Calculation

Market cap is the short version of market capitalization. It is the total market value to buy the whole company. It is equal to the share price times the number of shares outstanding.

Qingdao Haier Biomedical Co's Market Cap for the fiscal year that ended in Dec. 2023 is calculated as

Market Cap (A: Dec. 2023 )=Share Price (A: Dec. 2023 )*Shares Outstanding (EOP) (A: Dec. 2023 )
=¥40.52*317.953
=¥12,883

Qingdao Haier Biomedical Co's Market Cap for the quarter that ended in Sep. 2024 is calculated as

Market Cap (Q: Sep. 2024 )=Share Price (Q: Sep. 2024 )*Shares Outstanding (EOP) (Q: Sep. 2024 )
=¥34.9*317.953
=¥11,097

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Qingdao Haier Biomedical Co  (SHSE:688139) Market Cap Explanation

Market cap is not the real price you pay for a company. If you buy the company and become its owner, you become the owner of the cash the company has, and you also assume the company’s debt. The real price you pay is the Enterprise Value.

Warren Buffett uses the ratio of total market cap of all public traded companies over GDP to measure if the market is expensive. As of April 2012, the US total market cap is about $14.7 trillion, while the US GDP is about $15 trillion. The market was modestly overvalued.


Qingdao Haier Biomedical Co Market Cap Related Terms

Thank you for viewing the detailed overview of Qingdao Haier Biomedical Co's Market Cap provided by GuruFocus.com. Please click on the following links to see related term pages.


Qingdao Haier Biomedical Co Business Description

Traded in Other Exchanges
N/A
Address
No.1 Haier Road, Branding Building, Qingdao, CHN, 266101
Qingdao Haier Biomedical Co Ltd is engaged in designing, manufacturing, marketing and sales of low temperature storage equipment for biomedical samples. The company provides provides complete storage solutions for biological sample banks, blood safety, vaccine safety, medical supplies and reagent safety.
Executives
Jiang Lan Supervisors
Zhang Jiang Tao Core technical personnel
Liu Ji Yuan Core technical personnel
Teng Pei Kun Core technical personnel
Wang Guang Sheng senior management
Gong Yi Director
Huang Yan Li senior management
Chen Hai Tao Senior management, core technical personnel
Liu Zhan Jie Directors, senior managers, core technical personn
Mo Rui Juan senior management
Wang Wen Fu Director

Qingdao Haier Biomedical Co Headlines

No Headlines